Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
7.90 -0.37 / -4.47%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.90 0.00 / 0.00%
Volume: 53.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-19.8M-53.6M-83.5M-68.4M
Total Other Cash Flow5.6M8.4M10.8M19.0M
Funds From Operations-13.1M-44.1M-71.4M-47.6M
Funds From/For Other Operating Expenses21.2M20.2M-22.2M-106.0K
Net Cash Flow - Operating Activities-34.4M-64.3M-49.2M-47.5M
InvestingIncrease In Investments0.000.00-48.9M-88.9M
Decrease In Investments0.000.003.4M57.3M
Capital Expenditures-828.5K-1.4M-2.3M-1.4M
Net Cash Flow Investing-828.5K-1.4M-47.9M-33.0M
FinancingShort Term Borrowings0.
Long Term Borrowings0.0029.7M20.0M0.00
Long Term Debt Reduction0.
Net Proceeds Stock Sale4.7M83.2M5.1M114.5M
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing4.7M112.8M25.1M114.5M
Exchange RateEffect of Exchange Rate on Cash--
Net Change In Cash-30.4M47.1M-72.0M34.0M